Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Ischemic Heart Disease

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 61 articles: HTML format Text format

Single Articles

March 2020
1. VACCARO O, Nicolucci A, Lucisano G, Masulli M, et al
   Response to Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care".
   J Clin Endocrinol Metab. 2020;105.
   PubMed     Text format    
   
   
   
2. DE CARVALHO LSF, Coelho OR, Sposito AC
   Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care".
   J Clin Endocrinol Metab. 2020;105.
   PubMed     Text format    
   
   
   January 2020
3. SHAH VN, Bailey R, Wu M, Foster NC, et al
   Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
   J Clin Endocrinol Metab. 2020 Jan 19. pii: 5709622. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   
   
4. NEVES JS, Correa S, Baeta Baptista R, Bigotte Vieira M, et al
   Association of prediabetes with CKD progression and adverse cardiovascular outcomes: an analysis of the CRIC study.
   J Clin Endocrinol Metab. 2020 Jan 16. pii: 5707316. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   
   
5. 
   CORRIGENDUM FOR "The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials".
   J Clin Endocrinol Metab. 2020;105.
   PubMed     Text format    
   
   
   December 2019
6. ZHOU Y, Huang Y, Ji X, Wang X, et al
   Pioglitazone for the primary and secondary prevention of cardiovascular and renal outcomes in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis.
   J Clin Endocrinol Metab. 2019 Dec 11. pii: 5673086. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   
   November 2019
7. SHAIKH K, Ellenberg SS, Nakanishi R, Snyder PJ, et al
   Biomarkers and Non-Calcified Coronary Artery Plaque Progression in Older Men Treated with Testosterone.
   J Clin Endocrinol Metab. 2019 Nov 30. pii: 5648063. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   
   
8. RAZVI S, Leng O, Jabbar A, Bano A, et al
   Sample Timing, diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 study.
   J Clin Endocrinol Metab. 2019 Nov 26. pii: 5643808. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   
   
9. WU H, Xu L, Ballantyne CM
   sDietary and pharmacological fatty acids and cardiovascular health.
   J Clin Endocrinol Metab. 2019 Nov 2. pii: 5611200. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   
   October 2019
10. LEE AK, Woodward M, Wang D, Ohkuma T, et al
    The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
    J Clin Endocrinol Metab. 2019 Oct 7. pii: 5582233. doi: 10.1210.
    PubMed     Text format     Abstract available
    
    
    August 2019
11. GYAWALI P, Martin SA, Heilbronn LK, Vincent AD, et al
    Higher serum sex hormone-binding globulin (SHBG) levels are associated with incident cardiovascular disease (CVD) in men.
    J Clin Endocrinol Metab. 2019 Aug 7. pii: 5544495. doi: 10.1210/jc.2019-01317.
    PubMed     Text format     Abstract available
    
    
    
12. DI DALMAZI G, Fanelli F, Zavatta G, Ricci Bitti S, et al
    The steroid profile of adrenal incidentalomas: subtyping subjects with high cardiovascular risk.
    J Clin Endocrinol Metab. 2019 Aug 5. pii: 5542836. doi: 10.1210/jc.2019-00365.
    PubMed     Text format     Abstract available
    
    
    July 2019
13. MELHUS H, Michaelsson K, Larsson SC
    Serum Parathyroid Hormone and Risk of Coronary Artery Disease: Exploring Causality using Mendelian Randomization.
    J Clin Endocrinol Metab. 2019 Jul 16. pii: 5532038. doi: 10.1210/jc.2019-01063.
    PubMed     Text format     Abstract available
    
    
    June 2019
14. ALEKSANDROVA K, Drogan D, Weikert C, Schulze MB, et al
    Fatty Acid-Binding Protein 4 and Risk of Type 2 Diabetes, Myocardial Infarction and Stroke: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2019 Jun 18. pii: 5519297. doi: 10.1210/jc.2019-00477.
    PubMed     Text format     Abstract available
    
    
    
15. POTT J, Bae YJ, Horn K, Teren A, et al
    Genetic association study of eight steroid hormones and implications for sexual dimorphism of coronary artery disease.
    J Clin Endocrinol Metab. 2019 Jun 6. pii: 5511541. doi: 10.1210/jc.2019-00757.
    PubMed     Text format     Abstract available
    
    
    May 2019
16. VACCARO O, Lucisano G, Masulli M, Bonora E, et al
    Cardiovascular effects of pioglitazone or sulphonylureas according to pretreatment risk: moving towards personalized care.
    J Clin Endocrinol Metab. 2019 May 6. pii: 5485080. doi: 10.1210/jc.2019-00361.
    PubMed     Text format     Abstract available
    
    
    April 2019
17. HARADA M, Fujihara K, Osawa T, Yamamoto M, et al
    Relationship between Number of Multiple Risk Factors and Coronary Artery Disease Risk With and Without Diabetes Mellitus.
    J Clin Endocrinol Metab. 2019 Apr 17. pii: 5469228. doi: 10.1210/jc.2019-00168.
    PubMed     Text format     Abstract available
    
    
    
18. HIEMSTRA T, Lim K, Thadhani R, Manson JE, et al
    Vitamin D and Atherosclerotic Cardiovascular Disease.
    J Clin Endocrinol Metab. 2019 Apr 4. pii: 5426811. doi: 10.1210/jc.2019-00194.
    PubMed     Text format     Abstract available
    
    
    
19. BANO A, Chaker L, de Maat MPM, Atiq F, et al
    Thyroid function and cardiovascular disease: the mediating role of coagulation factors.
    J Clin Endocrinol Metab. 2019 Apr 2. pii: 5423567. doi: 10.1210/jc.2019-00072.
    PubMed     Text format     Abstract available
    
    
    March 2019
20. MORENO RC, Navas-Acien A, Escolar E, Nathan DM, et al
    Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 14. pii: 5376633. doi: 10.1210/jc.2018-01484.
    PubMed     Text format     Abstract available
    
    
    
21. EJLSMARK-SVENSSON H, Rolighed L, Rejnmark L
    Effect of Parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: A randomised clinical trial.
    J Clin Endocrinol Metab. 2019 Mar 12. pii: 5372733. doi: 10.1210/jc.2018-02456.
    PubMed     Text format     Abstract available
    
    
    February 2019
22. NATTERO-CHAVEZ L, Redondo Lopez S, Alonso Diaz S, Garnica Urena M, et al
    Association of cardiovascular autonomic dysfunction with peripheral arterial stiffness in patients with type 1 diabetes.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342945. doi: 10.1210/jc.2018-02729.
    PubMed     Text format     Abstract available
    
    
    
23. HUANG RC, Lillycrop KA, Beilin LJ, Godfrey KM, et al
    Epigenetic age acceleration in adolescence associates with BMI, inflammation and risk score for middle age cardiovascular disease.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342941. doi: 10.1210/jc.2018-02076.
    PubMed     Text format     Abstract available
    
    
    
24. SCHADE DS, Eaton RP
    A Simplified Approach to Reducing Cardiovascular Risk.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342943. doi: 10.1210/jc.2018-02509.
    PubMed     Text format     Abstract available
    
    
    
25. BEHESHTI S, Madsen CM, Varbo A, Nordestgaard BG, et al
    How to identify familial premature myocardial infarction: comparing approaches to identify familial hypercholesterolemia.
    J Clin Endocrinol Metab. 2019 Feb 7. pii: 5307688. doi: 10.1210/jc.2018-02261.
    PubMed     Text format     Abstract available
    
    
    
26. JUONALA M, Pitkanen N, Tolonen S, Laaksonen M, et al
    Childhood exposure to passive smoking and bone health in adulthood. The Cardiovascular Risk in Young Finns Study.
    J Clin Endocrinol Metab. 2019 Feb 1. pii: 5304739. doi: 10.1210/jc.2018-02501.
    PubMed     Text format     Abstract available
    
    
    January 2019
27. SKOV J, Sundstrom A, Ludvigsson JF, Kampe O, et al
    Sex-specific risk of cardiovascular disease in autoimmune Addison's disease - a population-based cohort study.
    J Clin Endocrinol Metab. 2019 Jan 3. pii: 5270381. doi: 10.1210/jc.2018-02298.
    PubMed     Text format     Abstract available
    
    
    November 2018
28. OH TJ, Moon JH, Choi SH, Lim S, et al
    Body-weight fluctuation and incident diabetes mellitus, cardiovascular disease, and mortality: a 16-year prospective cohort study.
    J Clin Endocrinol Metab. 2018 Nov 29. pii: 5214055. doi: 10.1210/jc.2018-01239.
    PubMed     Text format     Abstract available
    
    
    
29. GUASCH-FERRE M, Ruiz-Canela M, Li J, Zheng Y, et al
    Plasma acylcarnitines and risk of type 2 diabetes in a Mediterranean population at high cardiovascular risk.
    J Clin Endocrinol Metab. 2018 Nov 13. pii: 5172268. doi: 10.1210/jc.2018-01000.
    PubMed     Text format     Abstract available
    
    
    September 2018
30. TAMHANE S, Rodriguez-Gutierrez R, Iqbal AM, Prokop L, et al
    Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2018 Sep 28. pii: 5107761. doi: 10.1210/jc.2018-01862.
    PubMed     Text format     Abstract available
    
    
    
31. AL-SOFIANI ME, Yanek LR, Faraday N, Kral BG, et al
    Diabetes and Platelet Response to Low-dose Aspirin.
    J Clin Endocrinol Metab. 2018 Sep 27. pii: 5107300. doi: 10.1210/jc.2018-01254.
    PubMed     Text format     Abstract available
    
    
    
32. RITCHEY ME, Harding A, Hunter S, Peterson C, et al
    Cardiovascular Safety During and After Use of Phentermine and Topiramate.
    J Clin Endocrinol Metab. 2018 Sep 21. pii: 5104461. doi: 10.1210/jc.2018-01010.
    PubMed     Text format     Abstract available
    
    
    August 2018
33. STRAND E, Rebnord EW, Pedersen ER
    Response to letter to the Editor: Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Aug 14. pii: 5073239. doi: 10.1210/jc.2018-01647.
    PubMed     Text format    
    
    
    
34. LIEPINSH E, Dambrova M
    Letter to the Editor: Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Aug 14. pii: 5073236. doi: 10.1210/jc.2018-01408.
    PubMed     Text format    
    
    
    
35. EMANUELSSON F, Nordestgaard BG, Benn M
    Familial hypercholesterolemia and risk of peripheral arterial disease and chronic kidney disease.
    J Clin Endocrinol Metab. 2018 Aug 3. pii: 5063925. doi: 10.1210/jc.2018-01058.
    PubMed     Text format     Abstract available
    
    
    
36. HSU PF, Sung SH, Cheng HM, Shin SJ, et al
    Cardiovascular benefits of acarbose versus sulfonylureas in type 2 diabetic patients treated with metformin.
    J Clin Endocrinol Metab. 2018 Aug 2. pii: 5063484. doi: 10.1210/jc.2018-00040.
    PubMed     Text format     Abstract available
    
    
    July 2018
37. LYU Y, Luo Y, Li C, Guo X, et al
    Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China.
    J Clin Endocrinol Metab. 2018 Jul 3. pii: 5047769. doi: 10.1210/jc.2018-00422.
    PubMed     Text format     Abstract available
    
    
    May 2018
38. NICHOLS GA, Philip S, Reynolds K, Granowitz CB, et al
    Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005949. doi: 10.1210/jc.2018-00470.
    PubMed     Text format     Abstract available
    
    
    
39. PARK J, Blackburn BE, Ganz PA, Rowe K, et al
    Risk Factors for Cardiovascular Disease among Thyroid Cancer Survivors: Findings from the Utah Cancer Survivors Study.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005948. doi: 10.1210/jc.2017-02629.
    PubMed     Text format     Abstract available
    
    
    
40. THURSTON RC, Bhasin S, Chang Y, Barinas Mitchell E, et al
    Reproductive Hormones and Subclinical Cardiovascular Disease in Midlife Women.
    J Clin Endocrinol Metab. 2018 May 18. pii: 4999000. doi: 10.1210/jc.2018-00579.
    PubMed     Text format     Abstract available
    
    
    
41. OTTOSSON F, Smith E, Melander O, Fernandez C, et al
    Altered asparagine and glutamate homeostasis precede coronary artery disease and type-2 diabetes.
    J Clin Endocrinol Metab. 2018 May 16. pii: 4996516. doi: 10.1210/jc.2018-00546.
    PubMed     Text format     Abstract available
    
    
    April 2018
42. STAHLI BE, Nozza A, Schrieks IC, Buse JB, et al
    Homeostasis Model Assessment of Insulin Resistance and Survival in Patients with Diabetes and Acute Coronary Syndrome.
    J Clin Endocrinol Metab. 2018 Apr 6. pii: 4963641. doi: 10.1210/jc.2017-02772.
    PubMed     Text format     Abstract available
    
    
    March 2018
43. FAWAD A, Bergmann A, Struck J, Nilsson PM, et al
    Proneurotensin predicts cardiovascular disease in an elderly population.
    J Clin Endocrinol Metab. 2018 Mar 13. pii: 4931667. doi: 10.1210/jc.2017-02424.
    PubMed     Text format     Abstract available
    
    
    
44. KIM C, Aroda VR, Goldberg RB, Younes N, et al
    Response to Letter: Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2018 Mar 12. pii: 4931069. doi: 10.1210/jc.2018-00244.
    PubMed     Text format    
    
    
    
45. PASCHOU SA, Anagnostis P, Goulis DG, Siasos G, et al
    Letter to the Editor: Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2018 Mar 12. pii: 4931067. doi: 10.1210/jc.2018-00018.
    PubMed     Text format    
    
    
    February 2018
46. MEUN C, Franco OH, Dhana K, Jaspers L, et al
    High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study.
    J Clin Endocrinol Metab. 2018 Feb 1. pii: 4834041. doi: 10.1210/jc.2017-02421.
    PubMed     Text format     Abstract available
    
    
    January 2018
47. WU CJ, Kao TW, Chang YW, Peng TC, et al
    Does the additional component of calf-circumference refine metabolic syndrome in Correlating with Cardiovascular Risk?
    J Clin Endocrinol Metab. 2018 Jan 15. pii: 4802111. doi: 10.1210/jc.2017-02320.
    PubMed     Text format     Abstract available
    
    
    
48. DEGERUD E, Nygard O, de Vogel S, Hoff R, et al
    Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris.
    J Clin Endocrinol Metab. 2018 Jan 9. pii: 4794886. doi: 10.1210/jc.2017-02328.
    PubMed     Text format     Abstract available
    
    
    
49. STRAND E, Rebnord EW, Flygel MR, Lysne V, et al
    Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Jan 9. pii: 4794884. doi: 10.1210/jc.2017-02139.
    PubMed     Text format     Abstract available
    
    
    
50. YU D, Cai Y, Graffy J, Holman D, et al
    Development and external validation of risk scores for cardiovascular hospitalisation and rehospitalisation in diabetes patients.
    J Clin Endocrinol Metab. 2018 Jan 8. pii: 4792932. doi: 10.1210/jc.2017-02293.
    PubMed     Text format     Abstract available
    
    
    December 2017
51. KIM C, Aroda VR, Goldberg RB, Younes N, et al
    Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2017 Dec 6. pii: 4693937. doi: 10.1210/jc.2017-01829.
    PubMed     Text format     Abstract available
    
    
    October 2017
52. TROISI R, Titus L, Hatch EE, Palmer JR, et al
    A Prospective Cohort Study of Prenatal Diethylstilbestrol Exposure and Cardiovascular Disease Risk.
    J Clin Endocrinol Metab. 2017 Oct 20. doi: 10.1210/jc.2017-01940.
    PubMed     Text format     Abstract available
    
    
    
53. ANEKE-NASH CS, Xue X, Qi Q, Biggs ML, et al
    The Association between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study.
    J Clin Endocrinol Metab. 2017 Oct 12. doi: 10.1210/jc.2017-01273.
    PubMed     Text format     Abstract available
    
    
    September 2017
54. RHEE EJ, Cho JH, Kwon H, Park SE, et al
    Association Between Coronary Artery Calcification and the Hemoglobin Glycation Index: The Kangbuk Samsung Health Study.
    J Clin Endocrinol Metab. 2017 Sep 27. doi: 10.1210/jc.2017-01723.
    PubMed     Text format     Abstract available
    
    
    
55. PLAT J, Vreugdenhil ACE
    Response to Letter: Association of TSH With Cardiovascular Disease Risk in Overweight and Obese Children During Lifestyle Intervention.
    J Clin Endocrinol Metab. 2017 Sep 18. doi: 10.1210/jc.2017-01894.
    PubMed     Text format    
    
    
    
56. RADETTI G, Longhi S, Sartorio A, Grugni G, et al
    Letter to the Editor: Association of TSH With Cardiovascular Disease Risk in Overweight and Obese Children During Lifestyle Intervention.
    J Clin Endocrinol Metab. 2017 Sep 18. doi: 10.1210/jc.2017-01505.
    PubMed     Text format    
    
    
    
57. BERGTHORSDOTTIR R, Ragnarsson O, Skrtic S, Glad CAM, et al
    Visceral Fat and Novel Biomarkers of Cardiovascular Disease in Patients with Addison's Disease; a case-control study.
    J Clin Endocrinol Metab. 2017 Sep 13. doi: 10.1210/jc.2017-01324.
    PubMed     Text format     Abstract available
    
    
    
58. MARAKA S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, et al
    Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2017 Sep 13. doi: 10.1210/jc.2017-01643.
    PubMed     Text format     Abstract available
    
    
    
59. KANG YM, Cho YK, Lee SE, Park JY, et al
    Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study.
    J Clin Endocrinol Metab. 2017;102:3443-3451.
    PubMed     Text format     Abstract available
    
    
    August 2017
60. MONGRAW-CHAFFIN ML, Allison MA, Burke GL, Criqui MH, et al
    CT derived body fat distribution and incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
    J Clin Endocrinol Metab. 2017 Aug 16. doi: 10.1210/jc.2017-01113.
    PubMed     Text format     Abstract available
    
    
    February 2017
61. TOULIS KA, Willis BH, Marshall T, Kumarendran B, et al
    All-cause mortality in patients with diabetes under treatment with dapagliflozin: a population-based, open-cohort study in THIN database.
    J Clin Endocrinol Metab. 2017 Feb 20. doi: 10.1210/jc.2016-3446.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: